| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |